
Atazanavir 300 mg + Ritonavir 100 mg (Virataz R) is a combination antiretroviral medicine used to treat HIV-1 infection in adults and eligible adolescents. Atazanavir prevents HIV from multiplying, while Ritonavir boosts the effectiveness of Atazanavir by increasing its levels in the body. This combination is used as part of antiretroviral therapy (ART) and helps control HIV but does not cure it.
| Generic name | Atazanavir/Ritonavir |
| Strength | 300 mg + 100 mg |
| Manufacturer | HETERO |
| Package size | 30 Tablets |
| Used for | HIV-1 infection |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Atazanavir is a protease inhibitor that blocks the HIV protease enzyme, preventing the virus from producing mature infectious particles. Ritonavir acts as a pharmacokinetic booster, slowing the breakdown of Atazanavir in the liver. Together, they reduce the amount of HIV in the body and help protect the immune system.
Dr. Dhruv Patel is a qualified medical practitioner with a clinical interest in HIV care and long-term antiretroviral therapy. He helps patients understand how antiretroviral medicines control HIV and why consistent treatment is essential for maintaining viral suppression.